2022
DOI: 10.1038/s41390-022-02253-y
|View full text |Cite
|
Sign up to set email alerts
|

Neurometabolic changes in neonates with congenital heart defects and their relation to neurodevelopmental outcome

Abstract: Background Altered neurometabolite ratios in neonates undergoing cardiac surgery for congenital heart defects (CHD) may serve as a biomarker for altered brain development and neurodevelopment (ND). Methods We analyzed single voxel 3T PRESS H1-MRS data, acquired unilaterally in the left basal ganglia and white matter of 88 CHD neonates before and/or after neonatal cardiac surgery and 30 healthy controls. Metabolite ratios to Creatine (Cr) included glutamate… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 48 publications
(49 reference statements)
0
1
0
Order By: Relevance
“…Congenital heart disease (CHD) is the most common congenital birth defect in infants and young children, and children with CHD can experience different degrees of neurodevelopmental disorders. Early detection and scientific evaluation are conducive to timely clinical intervention, which is crucial for improving neurological function, development, and the quality of life of children with CHD [ 1 , 2 ]. The early clinical manifestations of nervous system dysplasia are not obvious, which complicates the diagnosis and treatment of this disease.…”
Section: Introductionmentioning
confidence: 99%
“…Congenital heart disease (CHD) is the most common congenital birth defect in infants and young children, and children with CHD can experience different degrees of neurodevelopmental disorders. Early detection and scientific evaluation are conducive to timely clinical intervention, which is crucial for improving neurological function, development, and the quality of life of children with CHD [ 1 , 2 ]. The early clinical manifestations of nervous system dysplasia are not obvious, which complicates the diagnosis and treatment of this disease.…”
Section: Introductionmentioning
confidence: 99%